483
Lydia Hernandez, M.D.Lydia Hernandez, M.D. – FDA 483, Sep 17, 2024
Record Details
An FDA inspection of Lydia Hernandez, M.D., a clinical investigator in Cincinnati, revealed significant deficiencies in the conduct of an investigational study. The firm failed to submit 15 serious adverse events to the sponsor within the required protocol timeframes, with delays ranging from 12 to 831 days. Additionally, records related to the return of investigational devices, including an investigational system and probes, were incomplete or missing.
View Company Profile
ID · a54fdf2e-5fb5-4573-86e8-75dd45fcc41c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.